Majem, M., Álvarez, R., Ortega, A. L., Ruiz de Alda, L., Gordo, R., García, J. F., Ivanova-Markova, Y., González-Domínguez, A., Sánchez San Cristóbal, R., & Rojo, F. (2022). Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain. Global and Regional Health Technology Assessment, 9(1), 82–90. https://doi.org/10.33393/grhta.2022.2449